Completed PHASE4 INTERVENTIONAL 2-arm NCT00799968

12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China (UKPTEC)

Efficacy and Safety Evaluation of 12-h and 2-h Urokinase Regimes in the Treatment of Pulmonary Thromboembolism: A Multi-Center, Randomized Controlled Trial in China

Sponsor: Beijing Chao Yang Hospital

Conditions Pulmonary Embolism Thromboembolism

Interventions Urokinase

Updated 6 times since 2017 Last updated: Nov 28, 2008 Started: Jun 30, 2002 Primary completion: Feb 28, 2006 Completion: Feb 28, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pulmonary Embolism and Thromboembolism and is currently completed. Beijing Chao Yang Hospital leads this study, which shows 6 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Feb 2017 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jun 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Chao Yang Hospital

Data source: Beijing Chao Yang Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Datong, China , Guangzhou, China , Hangzhou, China , Jinan, China , Nanning, China , Qingdao, China , Shenyang, China , Shenzhen, China , Shijiazhuang, China and 7 more locations